CIP
BHC icon

Convergence Investment Partners’s Bausch Health BHC Stock Holding History

Convergence Investment Partners’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-24
Closed – – 376
2018
Q1 		$0 Buy
+24
New +$447 ﹤0.01% 1025

Other funds holding BHC

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Convergence Investment Partners's BHC Position: Q2 2018 in Review

Convergence Investment Partners sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 24 shares.

Convergence Investment Partners first reported a position in BHC in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

  • Convergence Investment Partners reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 24 Bausch Health shares in Q2 2018.
  • Convergence Investment Partners first reported a position in Bausch Health in Q1 2018 and held it in 1 quarter.
  • Convergence Investment Partners's Bausch Health position peaked at $0 in Q1 2018.
  • 311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.